$DVAX
DYNAVAX TECHNOLOGIES CORP

2013 Q2 Form 10-Q Financial Statement

#000119312513211294 Filed on May 09, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2013 Q1 2012 Q1
Revenue $3.392M $2.085M $2.350M
YoY Change 26.38% -11.28% 34.75%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.640M $8.800M $5.790M
YoY Change 28.19% 51.99% 21.89%
% of Gross Profit
Research & Development $12.81M $14.16M $12.41M
YoY Change 12.56% 14.18% -15.45%
% of Gross Profit
Depreciation & Amortization $330.0K $320.0K $290.0K
YoY Change 10.0% 10.34% -52.46%
% of Gross Profit
Operating Expenses $12.81M $14.16M $12.41M
YoY Change 12.56% 14.18% -15.45%
Operating Profit -$17.05M -$20.88M -$15.85M
YoY Change 16.38% 31.75% -11.6%
Interest Expense $27.00K $32.00K $587.0K
YoY Change -95.42% -94.55% 19.8%
% of Operating Profit
Other Income/Expense, Net -$142.0K $14.00K -$122.0K
YoY Change -325.4% -111.48% 52.5%
Pretax Income -$17.16M -$20.83M -$16.51M
YoY Change 13.57% 26.17% -10.61%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$17.16M -$20.83M -$16.51M
YoY Change 13.59% 26.17% -10.62%
Net Earnings / Revenue -506.01% -998.8% -702.34%
Basic Earnings Per Share
Diluted Earnings Per Share -$938.2K -$1.139M -$1.062M
COMMON SHARES
Basic Shares Outstanding 182.9M shares 182.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q2 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $89.20M $105.4M $106.9M
YoY Change -44.32% -1.4% 100.94%
Cash & Equivalents $17.59M $25.02M $19.75M
Short-Term Investments $71.60M $80.40M $87.10M
Other Short-Term Assets $1.200M $1.200M $1.900M
YoY Change -70.73% -36.84% 26.67%
Inventory
Prepaid Expenses
Receivables $2.025M $1.547M $1.375M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $92.43M $108.1M $110.1M
YoY Change -44.2% -1.8% 97.35%
LONG-TERM ASSETS
Property, Plant & Equipment $8.038M $7.972M $6.962M
YoY Change 17.64% 14.51% 7.11%
Goodwill $2.436M $2.400M $2.498M
YoY Change 3.4% -3.92%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $463.0K $468.0K $438.0K
YoY Change 5.71% 6.85% -45.25%
Total Long-Term Assets $11.59M $11.48M $10.55M
YoY Change 12.84% 8.83% 8.78%
TOTAL ASSETS
Total Short-Term Assets $92.43M $108.1M $110.1M
Total Long-Term Assets $11.59M $11.48M $10.55M
Total Assets $104.0M $119.6M $120.7M
YoY Change -40.87% -0.87% 84.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.253M $1.727M $2.358M
YoY Change 8.48% -26.76% 24.11%
Accrued Expenses $7.307M $8.166M $6.301M
YoY Change -0.45% 29.6% -23.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $13.40M
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.91M $17.06M $25.82M
YoY Change -40.99% -33.92% 124.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $627.0K $621.0K $631.0K
YoY Change 1.79% -1.58% -89.66%
Total Long-Term Liabilities $627.0K $621.0K $631.0K
YoY Change 1.79% -1.58% -96.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.91M $17.06M $25.82M
Total Long-Term Liabilities $627.0K $621.0K $631.0K
Total Liabilities $19.35M $21.69M $26.45M
YoY Change -25.21% -17.97% -8.8%
SHAREHOLDERS EQUITY
Retained Earnings -$473.5M -$456.3M -$382.0M
YoY Change 19.22% 19.44%
Common Stock $183.0K $183.0K $157.0K
YoY Change 2.81% 16.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $84.66M $97.93M $88.38M
YoY Change
Total Liabilities & Shareholders Equity $104.0M $119.6M $120.7M
YoY Change -40.87% -0.87% 84.24%

Cashflow Statement

Concept 2013 Q2 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income -$17.16M -$20.83M -$16.51M
YoY Change 13.59% 26.17% -10.62%
Depreciation, Depletion And Amortization $330.0K $320.0K $290.0K
YoY Change 10.0% 10.34% -52.46%
Cash From Operating Activities -$15.69M -$18.89M -$8.181M
YoY Change 0.0% 130.85% -58.04%
INVESTING ACTIVITIES
Capital Expenditures -$290.0K $535.0K $932.0K
YoY Change -38.3% -42.6% 560.99%
Acquisitions
YoY Change
Other Investing Activities $8.490M $36.89M -$5.410M
YoY Change -121.82% -781.89% -131.56%
Cash From Investing Activities $8.210M $36.35M -$6.343M
YoY Change -120.85% -673.09% -137.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.00K 15.00K 2.253M
YoY Change -99.97% -99.33% 139.94%
NET CHANGE
Cash From Operating Activities -15.69M -18.89M -8.181M
Cash From Investing Activities 8.210M 36.35M -6.343M
Cash From Financing Activities 20.00K 15.00K 2.253M
Net Change In Cash -7.460M 17.48M -12.27M
YoY Change -149.83% -242.45% 688.62%
FREE CASH FLOW
Cash From Operating Activities -$15.69M -$18.89M -$8.181M
Capital Expenditures -$290.0K $535.0K $932.0K
Free Cash Flow -$15.40M -$19.42M -$9.113M
YoY Change 1.18% 113.11% -53.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
182891013 shares
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31941000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2052000
CY2012Q4 us-gaap Goodwill
Goodwill
2475000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
473000
CY2012Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
600000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
114826000
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
125085000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-640000
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
182792000 shares
CY2012Q4 us-gaap Liabilities
Liabilities
24926000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2166000
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
117531000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6785000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
629000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-435491000
CY2012Q4 us-gaap Assets
Assets
139752000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1005000
CY2012Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
46000
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
139752000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
652000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7599000
CY2012Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
1000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
182792000 shares
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-595000
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10063000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19014000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13806000 shares
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
45000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
183000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
5283000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
128187000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7965000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
550729000
CY2012Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
125130000
CY2012Q4 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
3.38
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19753000
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1217000
CY2013Q1 us-gaap Goodwill
Goodwill
2400000
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1595000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
61393000
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
468000
CY2013Q1 us-gaap Deferred Rent Credit
DeferredRentCredit
600000
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
97927000
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2294000
CY2013Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
105336000
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
6800000
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1814000
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-987000
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.41
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
182886000 shares
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2243000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
8625000 shares
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2193000
CY2013Q1 us-gaap Liabilities
Liabilities
21694000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1727000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
18953000
CY2013Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
80357000
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7167000
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
621000
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2343000
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
61367000
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-456316000
CY2013Q1 us-gaap Assets
Assets
119621000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.32
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1547000
CY2013Q1 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
37000
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
119621000
CY2013Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
80357000
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
644000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2065000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25016000
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
182886000 shares
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
80320000
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
3638000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
15089000 shares
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-950000
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8166000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
18964000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
17060000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16348000 shares
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
37000
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
183000
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4013000
CY2013Q1 us-gaap Assets Current
AssetsCurrent
108137000
CY2013Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
14306000
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7972000
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
555010000
CY2013Q1 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
105373000
CY2013Q1 dvax Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
105400000
CY2013Q1 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
3.31
CY2013Q1 dei Trading Symbol
TradingSymbol
DVAX
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
DYNAVAX TECHNOLOGIES CORP
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001029142
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
22964000
CY2013Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1905000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-20879000
CY2013Q1 us-gaap Revenue From Grants
RevenueFromGrants
760000
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-439000
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M17D
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000
CY2013Q1 us-gaap Contracts Revenue
ContractsRevenue
883000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21180000
CY2013Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-8000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y11D
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4266000
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.96
CY2013Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
50340000
CY2013Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-835000
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2013Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
57000 shares
CY2013Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
319000
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18886000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
36351000
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
72000
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-888000
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.50
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
535000
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
17417000
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8800000
CY2013Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
147000
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
542000
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-347000
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-355000
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14164000
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15000
CY2013Q1 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
6600000
CY2013Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
400000
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M5D
CY2013Q1 us-gaap Revenues
Revenues
2085000
CY2013Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
13454000
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2100000
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30800000 shares
CY2013Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-280000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
182847000 shares
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-20825000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2981000 shares
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-63000
CY2013Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><b>Use of Estimates</b></font></p> <p style="margin-top:6px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results may differ from these estimates.</font></p> </div>
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-8000
CY2013Q1 us-gaap License And Services Revenue
LicenseAndServicesRevenue
442000
CY2013Q1 us-gaap Interest Expense
InterestExpense
32000
CY2013Q1 dvax Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
-142000
CY2013Q1 dvax Increase Decrease In Restricted Cash And Other Assets For Operating Activities
IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities
-13000
CY2013Q1 dvax Proceeds From Stock Options And Restricted Shares Exercised
ProceedsFromStockOptionsAndRestrictedSharesExercised
10000
CY2013Q1 dvax Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
1000
CY2013Q1 dvax Share Based Compensation Arrangement By Share Based Payment Award Expiration Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationTerm
P10Y
CY2013Q1 dvax Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodTotalIntrinsicValue
2086000
CY2012Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
27425000
CY2012Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
738000
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2013Q1 dvax Reclassification Adjustments From Accumulated Other Comprehensive Income
ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome
0
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
18198000
CY2012Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1844000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-15848000
CY2012Q1 us-gaap Revenue From Grants
RevenueFromGrants
1087000
CY2012Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
318000
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-122000
CY2012Q1 us-gaap Contracts Revenue
ContractsRevenue
929000
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16076000
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2322000
CY2012Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
292000
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8181000
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6343000
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
52000
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-946000
CY2012Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
547000
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
932000
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-12188000
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5793000
CY2012Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
128000
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8152000
CY2012Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
429000
CY2012Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
429000
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12405000
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2253000
CY2012Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
400000
CY2012Q1 us-gaap Revenues
Revenues
2350000
CY2012Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
32836000
CY2012Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-304000
CY2012Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
155431000 shares
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39300000 shares
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-16505000
CY2012Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
83000
CY2012Q1 us-gaap License And Services Revenue
LicenseAndServicesRevenue
334000
CY2012Q1 us-gaap Interest Expense
InterestExpense
587000
CY2012Q1 dvax Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
1054000
CY2012Q1 dvax Increase Decrease In Restricted Cash And Other Assets For Operating Activities
IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities
83000
CY2012Q1 dvax Proceeds From Stock Options And Restricted Shares Exercised
ProceedsFromStockOptionsAndRestrictedSharesExercised
1071000
CY2012Q1 dvax Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
5000
CY2012Q1 dvax Reclassification Adjustments From Accumulated Other Comprehensive Income
ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome
0

Files In Submission

Name View Source Status
0001193125-13-211294-index-headers.html Edgar Link pending
0001193125-13-211294-index.html Edgar Link pending
0001193125-13-211294.txt Edgar Link pending
0001193125-13-211294-xbrl.zip Edgar Link pending
d512332d10q.htm Edgar Link pending
d512332dex311.htm Edgar Link pending
d512332dex312.htm Edgar Link pending
d512332dex321.htm Edgar Link pending
d512332dex322.htm Edgar Link pending
dvax-20130331.xml Edgar Link completed
dvax-20130331.xsd Edgar Link pending
dvax-20130331_cal.xml Edgar Link unprocessable
dvax-20130331_def.xml Edgar Link unprocessable
dvax-20130331_lab.xml Edgar Link unprocessable
dvax-20130331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending